Ptc Therapeutics (PTCT) Operating Margin Growth (3y) (2015 - 2026)
Powered by 
Analysis
Ptc Therapeutics (PTCT) Operating Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -2,649.00 |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 30,461.00 |
| 10 | Ptc Therapeutics | 5.79 Bn | 3.56 Bn | 340.60 Mn | 13,933.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13,933.00 |
| Mar 31, 2026 | 6,986.00 |
| Dec 31, 2025 | 7,634.00 |
| Sep 30, 2025 | 3,283.00 |
| Jun 30, 2025 | 3,626.00 |
| Mar 31, 2025 | 14,067.00 |
| Dec 31, 2024 | -2,490.00 |
| Sep 30, 2024 | 3,939.00 |
| Jun 30, 2024 | 6,287.00 |
| Mar 31, 2024 | 6,159.00 |
| Dec 31, 2023 | 9,175.00 |
| Sep 30, 2023 | -1,355.00 |
| Jun 30, 2023 | 15,090.00 |
| Mar 31, 2023 | 8,286.00 |
| Dec 31, 2022 | -3,026.00 |
| Sep 30, 2022 | 5,328.00 |
| Jun 30, 2022 | -1,048.00 |
| Mar 31, 2022 | 7,086.00 |
| Dec 31, 2021 | 131.00 |
| Sep 30, 2021 | 2,291.00 |